We appreciate Dr. Erol\'s ([@B1]) interest in our article describing the phenotype of fat cell--specific *rictor* knockout (FRic^−/−^) mice ([@B2]). Dr. Erol suggested that RBP4 may play a role in the development of insulin resistance in FRic^−/−^ mice. RBP4 is an adipokine, whose elevated expression in, and secretion from, adipocytes correlates with the development of insulin resistance in various animal models including the fat cell--specific GLUT4 knockout (G4A^−/−^) mice ([@B3]). Elevated circulating levels of RBP4 have also been demonstrated in insulin-resistant obese subjects and type 2 diabetic patients ([@B4]). Although a role for adipocyte-RBP4 as a regulator of whole-body insulin sensitivity is suggested, little is known about the regulation of the expression and secretion of RBP4 in adipocytes.

We agree that loss of adipocyte GLUT4 in G4A^−/−^ mice ([@B3]) and decreased GLUT4 expression in insulin-resistant human subjects ([@B3],[@B4]) are associated with an increase in expression and secretion of RBP4. However, it is not known whether the adipocyte-RBP4 response is caused by the reduction in total GLUT4 levels or because of the resulting decrease in insulin-stimulated glucose influx. We did not measure whether RBP4 was altered in FRic^−/−^ mice. However, we do not think that RBP4 is the cause of the systemic insulin resistance that was observed in FRic^−/−^ mice. Insulin-stimulated glucose uptake is impaired in FRic^−/−^ adipocytes because of changes in insulin signaling and defective GLUT4 translocation to the plasma membrane in the absence of rictor ([@B2]). Total GLUT4 levels are not changed in the FRic^−/−^ adipocytes ([@B2]). The decrease in basal glucose uptake in FRic^−/−^ adipocytes ([@B2]) does not support Dr. Erol\'s model whereby decreased insulin-stimulated glucose uptake induces increased basal glucose uptake. In FRic^−/−^ mice, loss of *rictor* expression does not only lead to impaired GLUT4 translocation to the plasma membrane, but multiple other defects ([@B2]). Most importantly, FRic^−/−^ mice show dysregulation of lipolysis and increased circulating nonesterified fatty acid ([@B2]), a condition not observed in G4A^−/−^ mice ([@B5]). Because it is very well known that an increase in circulating nonesterified fatty acid is sufficient to cause insulin resistance ([@B6]), this finding alone is sufficient to explain the insulin resistance observed in the FRic^−/−^ mice.
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